Skip to content

Study for the effectiveness of arthroscopic release of gluteal muscle contracture and joint capsule: a prospective randomized, parallel controlled trial

Study for the effectiveness of arthroscopic release of gluteal muscle contracture and joint capsule: a prospective randomized, parallel controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019829
Enrollment
Unknown
Registered
2018-12-02
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gluteal muscle contracture

Interventions

Group 1:arthroscopic release of gluteal muscle contracture and joint capsule
Group 2:arthroscopic release of gluteal muscle contracture

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-50 years old male or female; 2. Patients diagnosed with gluteal muscle contraction and adduction activity of hip joint <0 degree; 3. The patient receives gluteal muscle contraction for the first time; 4. Patients who voluntarily sign informed consent, should have sufficient language comprehension and voluntarily complete the entire study in according to the relevant research program; Patients after hip arthroscopy are not excluded; Note: All the above items are eligible for inclusion.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal hip structures, including hip osteoarthritis, developmental dysplasia of the hip, and hip joint fractures; 2. Patients with hip synovitis such as rheumatism, rheumatoid and gout; 3. Patients with suppurative, tuberculous or other types of hip infections; 4. Patients with hip ligament injury; 5. Patients who have undergone gluteal muscle contraction; 6. Patients with previous history of metabolic diseases and psychosis; 7. Patients who have undergone total hip arthroplasty or hemiarthroplasty; 8. Patients considered by the investigator not suitable for inclusion; 9. Patients who participated in another clinical trial within six months (including drug clinical trials); 10. Patients who have undergone knee arthroplasty.

Design outcomes

Primary

MeasureTime frame
the range of hip joint mobility;Harris Hip Score;Non-arthritic hip score;

Countries

China

Contacts

Public ContactXintao Zhang

Peking University Shenzhen Hospital

zhangxintao@sina.com+86 13500061856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026